Analyse SMC stock

Confirmed: The consensus price target of 441.83 EUR is around +18.1% above the current price of 374.18 EUR and therefore within the required plausibility range of ±25%.

Quantitative: With a current P/E ratio of 24.64the rating for a high-quality, defensive medical technology/diagnostics profile is not obviously excessive. The target roughly implies a forward/normalization multiple in the range of current valuation plus moderate earnings growth. Compared to the 52-week high of EUR 486.8, the target is still below previously accepted market prices, but at the same time clearly above the 52-week low of EUR 245.59, which refle...